Showing results (31-40 of 72) with videos related to

Sort By:
Pageof 8
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 3, 2010
Reduced-intensity conditioning allogeneic hematopoietic cell transplantation for patients with hematologic malignancies who relapse following autologous transplantation: a multi-institutional prospective study from the Cancer and Leukemia Group B (CALGB trial 100002)Asad Bashey, Kouros Owzar, Jeffrey L Johnson, et al.
Journal of Geriatric Oncology|July 10, 2018
Use of a comprehensive frailty assessment to predict morbidity in patients with multiple myeloma undergoing transplantAshley E Rosko, Ying Huang, Don M Benson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2008
Phase I study of GTI-2040, an antisense to ribonucleotide reductase, in combination with high-dose cytarabine in patients with acute myeloid leukemiaRebecca B Klisovic, William Blum, Xiaohui Wei, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 22, 2013
Optimizing autologous stem cell mobilization strategies to improve patient outcomes: consensus guidelines and recommendationsSergio Giralt, Luciano Costa, Jeffrey Schriber, et al.
Bone Marrow Transplantation|February 16, 2018
Psychosocial risk predicts high readmission rates for hematopoietic cell transplant recipientsDaniel R Richardson, Ying Huang, Heather L McGinty, et al.
Blood Advances|September 7, 2021
Dasatinib and dexamethasone followed by hematopoietic cell transplantation for adults with Ph-positive ALLMatthew J Wieduwilt, Jun Yin, Meir Wetzler, et al.
Pageof 8